Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Hydralazine (apresoline) manufacturing plant cost?

See the DrugPatentWatch profile for Hydralazine

Hydralazine (Apresoline) manufacturing plant cost isn’t a single fixed number—what you spend depends heavily on whether you’re:

  1. Making hydralazine as an API (active pharmaceutical ingredient)
  2. Making finished dosage forms (e.g., tablets/injectables) from that API
  3. The scale (e.g., pilot vs commercial),
  4. Regulatory expectations (US FDA cGMP vs EU GMP), and
  5. Whether the plant is new-build or a conversion/fit-out of existing space.

Because hydralazine is an older, generic product, many companies don’t publish detailed capex publicly, so estimates are usually derived from typical cGMP build-out benchmarks.

Typical cost ranges (very rough industry estimates)

A) API manufacturing facility (cGMP for API synthesis)

  • Greenfield new build: often ~$50M to $200M+
  • Smaller/off-the-shelf or modular capacity (if available): could be ~$20M to $80M

B) Finished-dose manufacturing (tablets/capsules or sterile injectable fill-finish)

  • Solid oral dosage plant (non-sterile): often ~$10M to $60M
  • Sterile injectables (fill-finish, aseptic processing): often ~$50M to $150M+, depending on cleanroom class, aseptic fill lines, and capacity

C) If you’re only doing packaging/labelling from sourced API

  • Typically ~$1M to $10M (depends on line count, quality systems, and storage)

What usually drives hydralazine facility cost up/down

  • Route complexity & isolation steps (API route affects number of unit operations, effluent handling, and containment)
  • Wastewater/solvent handling and environmental permits
  • Containment/odors/hazard handling
  • Quality systems: QC labs, stability chambers, microbiology (if sterile)
  • Sterility requirements (for injectable hydralazine): cleanroom and aseptic controls are the big cost driver
  • Capacity: early-phase plants can be dramatically cheaper than full commercial-scale

Quick clarifying questions (so I can narrow it)

  1. Are you estimating API production or finished product (tablets vs injectable)?
  2. Target capacity: tons/year API or units/year of finished product?
  3. Country/region (US/EU/India/China) and the regulatory standard you want to meet?

If you answer those, I can give a tighter order-of-magnitude estimate and outline a typical cost breakdown (buildings/cleanrooms, equipment, utilities, QC lab, validation/engineering, and initial working capital).



Other Questions About Hydralazine :

Hydralazine vs clonidine? Can hydralazine be used during pregnancy for high blood pressure? Hydralazine lupus like syndrome? Hydralazine brands? Hydralazine patent 1966? Hydralazine lupus? Is hydralazine good for high blood pressure?